CD38 in Macrophages Drives Uterine Aging by Depleting NAD+
A new study reveals how immune cells accelerate endometrial aging via NAD+ depletion — and how restoring NAD+ may reverse it.
Riepilogo
Researchers identified NAD+ depletion as a hallmark of endometrial aging in mice, driven primarily by CD38-expressing macrophages infiltrating the uterus. Using metabolomics, single-cell RNA sequencing, and genetic mouse models, they showed that myeloid-derived CD38 consumes NAD+ in the uterine microenvironment, promoting stromal cell senescence and impairing implantation. Supplementing aged mice with NAD+ precursors alleviated senescence markers, improved endometrial architecture, and restored embryo implantation rates. These findings establish a macrophage–NAD+ axis as a central driver of reproductive aging and identify CD38 as a potential therapeutic target for improving fertility in older women.
Riepilogo Dettagliato
As more women delay childbearing into their late 30s and 40s, understanding why the aging uterus fails to support implantation has become a pressing clinical question. Even when embryo quality is optimized through assisted reproduction, pregnancy rates in women over 40 remain persistently low — pointing to the endometrium itself as a key limiting factor. This study set out to identify the metabolic and cellular mechanisms underlying age-related endometrial dysfunction.
Researchers collected uterine tissues from young (3-month), middle-aged (8-month), and aged (12-month) mice at embryonic day 4 — the peri-implantation stage equivalent to the window of implantation. Untargeted global metabolomics of 843 metabolites revealed that NAD+ depletion was the most consistent metabolic hallmark of aging uteri, accompanied by disruptions in amino acid, carbohydrate, and energy metabolism and a measurable drop in ATP levels. Aged endometria also showed increased fibrotic deposition, reduced endometrial thickness, and accumulation of senescent cells detected by SPiDER-βGal staining.
Single-cell RNA sequencing of peri-implantation uteri provided cellular resolution to these findings, identifying an expansion of senescent stromal cell populations in aged animals alongside a decline in NAD+ levels. Critically, the scRNA-seq data also revealed a marked increase in CD38-expressing macrophages in aged uteri. CD38 is a well-characterized NAD+-consuming ectoenzyme known to drive tissue-level NAD+ decline in aging. Pharmacological inhibition of CD38 and myeloid-specific CD38 knockout mice both demonstrated that macrophage-derived CD38 is a principal driver of uterine NAD+ loss. Depleting this enzyme preserved stromal NAD+ levels, reduced senescence burden, and improved uterine receptivity markers.
Supplementation with NAD+ precursors (such as NMN or NR) in aged mice recapitulated these benefits: stromal senescence was attenuated, endometrial architecture improved, and embryo implantation rates were restored toward those seen in young animals. These results position the macrophage–CD38–NAD+ axis as a central physiological integrator linking immune aging to reproductive failure.
This work is notable for connecting innate immune remodeling in the aging uterus to a targetable metabolic mechanism. However, the study was conducted entirely in mice, and whether CD38+ macrophage expansion and NAD+ depletion occur similarly in human endometrium at advanced maternal age requires direct investigation. The translational path from mouse models to clinical NAD+ precursor supplementation or CD38 inhibition in women with implantation failure will also require careful safety evaluation.
Risultati Principali
- NAD+ depletion was the dominant metabolic feature of endometrial aging in mice at the peri-implantation stage.
- Single-cell RNA sequencing revealed expanded senescent stromal cell populations and increased CD38+ macrophages in aged uteri.
- Myeloid-specific CD38 knockout preserved uterine NAD+ levels, reduced stromal senescence, and improved implantation.
- NAD+ precursor supplementation in aged mice restored embryo implantation competence and reduced endometrial fibrosis.
- CD38 is identified as a central driver linking macrophage activity to NAD+ loss and reproductive aging.
Metodologia
The study used uterine tissues from mice aged 3, 8, and 12 months collected at embryonic day 4. Methods included untargeted global metabolomics (843 metabolites), single-cell RNA sequencing, immunofluorescence, H&E and Masson's trichrome staining, myeloid-specific CD38 knockout mouse models, and NAD+ precursor supplementation experiments.
Limitazioni dello Studio
All experiments were conducted in mice; direct evidence in human endometrial aging is lacking and must be established before clinical translation. The study does not address long-term safety or optimal dosing of NAD+ precursors in a reproductive context, nor does it fully disentangle CD38-independent contributors to age-related NAD+ decline.
Ti è piaciuto questo riepilogo?
Ricevi ogni settimana le ultime ricerche sulla longevità direttamente nella tua casella email.
Inserisci la tua email per iscriverti: